Literature DB >> 7429326

A new bioassay of VIP: results in watery diarrhoea syndrome.

M C Laburthe, C M Dupont, J D Besson, M Rousset, G E Rosselin.   

Abstract

Cyclic AMP accumulation in human colon adenocarcinoma cells in culture (HT-29) is known to be particularly sensitive to the stimulating action of vasoactive intestinal peptide (VIP). This property was exploited as a means of investigating the possible role of VIP as a humoral mediator in the watery diarrhoea syndrome. Our results showed that plasma from two patients with watery diarrhoea syndrome associated with ganglioneuroblastoma and pheochromocytoma strongly stimulated cyclic AMP accumulation in HT-29 cells, whereas plasma from normal subjects and patients with other diarrhoeal disorders had no effect. The stimulation induced by serial dilutions of plasma from patients paralleled the VIP-induced response. Preincubation of these plasmas with specific anti-VIP antibody prevented their stimulatory effects. Plasma sampled after the arrest of diarrhoea (spontaneous or after surgical resection of tumours) elicited AMP rise in HT-29 cells. Tumour extract stimulated cyclic AMP accumulation in HT-29 cells with a dose-response curve which was superimposable on the one obtained with standard VIP. The results lend support to the hypothesis that VIP is a humoral mediator in WDS and suggest that the diarrhoea is mediated through a VIP-induced accumulation of cyclic AMP in intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7429326      PMCID: PMC1419890          DOI: 10.1136/gut.21.7.619

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors.

Authors:  S I Said; G R Faloona
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

Review 2.  Radioimmunoassay of gastrointestinal hormones.

Authors:  E Straus
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

3.  Vasoactive intestinal peptide and watery-diarrhoea syndrome.

Authors:  S R Bloom; J M Polak; A G Pearse
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

4.  Cyclic AMP production in isolated colonic epithelial crypts: a highly sensitive model for the evaluation of vasoactive intestinal peptide action in human intestine.

Authors:  C Dupont; M Laburthe; J P Broyart; D Bataille; G Rosselin
Journal:  Eur J Clin Invest       Date:  1980-02       Impact factor: 4.686

5.  Plasma VIP in patients with watery diarrhea syndrome.

Authors:  J D Gardner
Journal:  Am J Dig Dis       Date:  1978-04

6.  Vasoactive intestinal peptide (VIP): variation of the jejuno-ileal content in the developing rat as measured by radioreceptorassay.

Authors:  M Laburthe; D Bataille; G Rosselin
Journal:  Acta Endocrinol (Copenh)       Date:  1977-03

7.  Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo.

Authors:  G J Krejs; R M Barkley; N W Read; J S Fordtran
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

8.  [Intestinal vasoactive peptide receptors in enterocytes : specific binding and stimulation of cyclic AMP].

Authors:  M Laburthe; J Besson; D H Bon Hoa; G Rosselin
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1977-06-06

9.  Vasoactive intestinal peptide (VIP): tissue distribution in the rat as measured by radioimmunoassay and by radioreceptorassay.

Authors:  J Besson; M Laburthe; D Bataille; C Dupont; G Rosselin
Journal:  Acta Endocrinol (Copenh)       Date:  1978-04

10.  Experimental evidence for vasoactive intestinal peptide as the cause of the watery diarrhea syndrome.

Authors:  I M Modlin; S R Bloom; S J Mitchell
Journal:  Gastroenterology       Date:  1978-12       Impact factor: 22.682

View more
  3 in total

Review 1.  Pathogenesis and pharmacology of diarrhea.

Authors:  L Ooms; A Degryse
Journal:  Vet Res Commun       Date:  1986-09       Impact factor: 2.459

2.  Immunohistochemical study of pheochromocytomas. An investigation of methionine-enkephalin, vasoactive intestinal peptide, somatostatin, corticotropin, beta-endorphin, and calcitonin in 16 tumors.

Authors:  J Hassoun; G Monges; P Giraud; J F Henry; C Charpin; H Payan; M Toga
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

3.  Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.

Authors:  A Couvineau; M Rousset; M Laburthe
Journal:  Biochem J       Date:  1985-10-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.